Swedish researchers developing new treatment for chronic hepatitis B and D infections
A new immunological treatment against hepatitis B and D viruses, both of which can cause…
A new immunological treatment against hepatitis B and D viruses, both of which can cause…
The National Institute of Allergy and Infectious Disease (NIAID) has awarded a $6.9 million grant…
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharma company focused on the development of innovative therapies to…
Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains…
Phase II results from Dutch biotech CyTuVax show its enhanced hepatitis B vaccine reduces non-responders…
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…
European and African researchers are developing a hepatitis B blood test that could help identify…
Scientists in London are the first in the world to test how pathogens like the…
The French biotech‘s hepatitis B vaccine has demonstrated good efficacy and safety, suggesting it could…
Enyo Pharma has announced that its lead candidate EYP001, indicated for the treatment of hepatitis…
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
While everybody wants to get the next immunotherapy on the market, Roche is turning its…